Skip to content

Application of virtual reality technology in pain management of cancer patients: Impact on opioid consumption and cancer-related adverse symptoms(Pre-riment)

Impact of applying virtual reality technology on the dose of opioids used in the treatment of cancer patients: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077344
Enrollment
Unknown
Registered
2023-11-06
Start date
2023-11-08
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer patients

Interventions

Virtual reality technology treatment group:Virtual reality technology therapy + Standardized pain management
Standardized pain management group:Standardized pain management

Sponsors

The People's Hospital of Jizhou District, Tianjin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Chronic pain patients caused by various tumor diseases; 2.Age 18-80 years old; Diagnosed with mid to late stage cancer; While taking opioid drugs; 3.Conscious and able to accurately express the extent of pain and related adverse symptoms.

Exclusion criteria

Exclusion criteria: 1.Primary brain lesion; previous mental illness or cognitive impairment; Brain tumor or brain metastasis; 2.Primary limb movement disorder; 3.Presence of visual and auditory impairment; 4.Patients with liver diseases such as primary liver cancer and hepatitis B that have caused liver function damage.

Design outcomes

Primary

MeasureTime frame
Overall consumption of opioid drugs;

Secondary

MeasureTime frame
VAS Pain Rating Scale;SAI State Anxiety Scale;PSQI Sleep Quality Index Scale;Beck Depression Self Rating Scale;Pipper Fatigue Scale;ALT;AST;Bilirubin;TNF-a;INF;IL-1;IL-2;IL-6;Breakout pain;

Countries

China

Contacts

Public ContactLi Yan

The People's Hospital of Jizhou District, Tianjin

liyanmanu@163.com+86 156 0019 4996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026